Fujitsu has introduced a groundbreaking AI agent platform designed to enhance operational efficiency and ensure stable medical service provision in Japan's healthcare sector. Supported by NVIDIA’s advanced AI technology, this platform features a centralized orchestrator AI agent that coordinates specialized healthcare AI agents, streamlining workflows and driving transformation in medical operations. This initiative aligns with Fujitsu’s commitment to revolutionizing healthcare through data and AI, fostering sustainable and personalized medical solutions.
Fujitsu launches AI agent platform for Japan’s healthcare sector.
Features orchestrator AI for seamless workflow automation.
Supported by NVIDIA’s NIM microservices and Blueprints.
Aims to enhance efficiency and ensure stable medical services.
Set for commercialization in 2025 with global partnerships.
Aligns with Fujitsu Uvance for personalized healthcare solutions.
Fujitsu’s AI agent platform is poised to redefine healthcare operations in Japan by integrating a suite of task-specific AI agents. These agents, developed by Fujitsu and its partners, focus on critical medical workflows such as data structuring and interoperability monitoring. The platform’s orchestrator AI agent centralizes control, automating complex processes both within and outside medical institutions. This approach ensures rapid adoption of world-leading medical practices, enhancing operational efficiency and sustainability.
The development of this platform leverages NVIDIA’s cutting-edge AI technologies, including NIM microservices and Blueprints, combined with Fujitsu’s deep expertise in Japanese medical information systems. This partnership enables the platform to deliver scalable, secure, and efficient solutions that address the unique challenges of the healthcare sector. By harnessing NVIDIA’s accelerated computing, Fujitsu aims to set a global benchmark for medical operational excellence.
Fujitsu plans to accelerate the platform’s commercialization in 2025 by collaborating with advanced medical institutions and global partners. These collaborations will validate the effectiveness of the healthcare orchestrator AI agent and enable the development of industry-specific AI agents tailored to diverse medical needs. This strategic approach ensures the platform’s adaptability and scalability across various healthcare environments.
Under its Fujitsu Uvance business model, Fujitsu is dedicated to addressing societal challenges through innovation. The AI agent platform supports this mission by advancing personalized treatment opportunities and improving individual well-being. By streamlining workflows and reducing operational burdens, the platform empowers healthcare professionals to focus on patient care, ultimately transforming the healthcare landscape.
Fujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.